Overview

Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu

Status:
Suspended
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
National clinical trial, phase III, multicenter, randomized, prospective, double-blind, parallel, placebo-controlled, which one hundred and fifty (150) subjects of both sexes aged equal or more than 18 years will be randomly allocated to one the drug group or placebo group.
Phase:
Phase 3
Details
Lead Sponsor:
Ache Laboratorios Farmaceuticos S.A.
Treatments:
Desloratadine
Ibuprofen
Loratadine
Oxymetazoline
Phenylephrine